KHALID IBRAHIM, D.; AKRAM YAHYA, N. Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi Journal of Pharmacy, [S. l.], v. 20, n. 2, p. 168–173, 2023. DOI: 10.33899/iphr.2023.141712.1048. Disponível em: https://jwups.uomosul.edu.iq/index.php/iphr/article/view/40453. Acesso em: 27 sep. 2025.